CStone Pharmaceuticals- B (09966.HK): JSKN003 was granted orphan drug designation by the US FDA for the treatment of GC/GEJ.

Zh tng cijng APP xn, kngnng jiru zh yo-B (09966.HK) fb gnggo, JSKN003 y hu migu shpn yo chn rn gunl j (FDA) shu y g'r yo zg rndng (ODD), yngy zhlio wi i j wi shj hunyn (GC/GEJ). The Jingtong Finance APP news, Kangning Jerui Pharmaceutical-B (09966.HK) announced that JSKN003 has been granted orphan drug designation (ODD) by the US Food and Drug Administration (FDA) for the treatment of gastric cancer and gastroesophageal junction cancer (GC/GEJ).